Replies to post #443570 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Ex is right. NWBO’s forthcoming (currently still an application) combo patent is broad enough to handle DCVax-l and any upgrades and stop competitors from creating an end around. You would not want it narrow, Remember it’s NWBO’s IP. Imho.